Publicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (20)

2024

  1. Dispersal history of SARS-CoV-2 in Galicia, Spain

    Journal of Medical Virology, Vol. 96, Núm. 7

  2. Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain

    Emerging Microbes and Infections

  3. Oral specimens as a tool for accurate metagenomic analysis: A pilot study

    Journal of Stomatology, Oral and Maxillofacial Surgery, Vol. 125, Núm. 5

2023

  1. Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract

    Journal of Infection, Vol. 87, Núm. 6, pp. 538-550

  2. Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial

    Pharmaceutics, Vol. 15, Núm. 2

2022

  1. A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity

    Environmental Research, Vol. 210

  2. Characterisation of the blood RNA host response underpinning severity in COVID-19 patients

    Scientific Reports, Vol. 12, Núm. 1

  3. Oral microbiome and systemic antineoplastics in cancer treatment: A systematic review

    Medicina oral, patologia oral y cirugia bucal, Vol. 27, Núm. 3, pp. e248-e256

  4. Risk Factors of Mortality in Hospitalized Patients With COVID-19 Applying a Machine Learning Algorithm

    Open Respiratory Archives, Vol. 4, Núm. 2

  5. The unexpected high prevalence of HBV subgenotype D4 in patients with chronic hepatitis B in Galicia, a northwestern Spanish region, reflects strong links with Latin America

    Journal of Clinical Virology, Vol. 153

2021

  1. Development and characterization of inhaled ethanol as a novel pharmacological strategy currently evaluated in a phase ii clinical trial for early-stage sars-cov-2 infection

    Pharmaceutics, Vol. 13, Núm. 3

  2. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  3. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations

    British Journal of Clinical Pharmacology, Vol. 86, Núm. 8, pp. 1661-1666

  2. Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic-Pharmacokinetic Prospective Multicenter Study

    Pharmacotherapy, Vol. 40, Núm. 1, pp. 17-25

2019

  1. An Observational Study of the Efficacy and Safety of Voriconazole in a Real-Life Clinical Setting

    Journal of Chemotherapy, Vol. 31, Núm. 1, pp. 49-57

  2. Comparative evaluation of the identification of rapidly growing non-tuberculous mycobacteria by mass spectrometry (MALDI-TOF MS), GenoType Mycobacterium CM/AS assay and partial sequencing of the rpoβ gene with phylogenetic analysis as a reference method

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 3, pp. 160-166

2017

  1. Granulomatous variant of pigmented purpuric dermatosis: report of two cases and review of the literature

    JDDG - Journal of the German Society of Dermatology

  2. Granulomatöse Pigmentpurpura: Bericht über zwei Fälle und Literaturüberblick

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

2016

  1. The genotypic study of Mycobacterium tuberculosis complex resistant to isoniazid: Galicia, Spain (2008–2013)

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 35, Núm. 11, pp. 1795-1801